Mind Medicine (MindMed) Inc N.MMED

Primary Symbol: MNMD Alternate Symbol(s): N.MMED.WA | N.MMED.WR | N.MMED.WS

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > mmed

<< Previous

Bullboard Posts

Next >>

Comment by Starkickeron Apr 12, 2024 3:06pm

146 Views

Post# 35986426

RE:mmed

You might have to call your broker to request a transfer to NSDQ otjerwise the shares will show up in your account but the values won't and you won't be able to trade them. Only takes one to two business days to transfer.

<< Previous

Bullboard Posts

Next >>

Red Light Holland and Costco Canada partner on mushroom kits